1. Home
  2. CDXS
  3. CDXS News

Latest Codexis Inc. (CDXS) News on January 22, 2025

Codexis Appoints Christos Richards to Board of Directors
CDXS

GlobeNewswire

6 days ago

Codexis Appoints Christos Richards to Board of Directors

Codexis Announces New Employment Inducement Grants
CDXS

GlobeNewswire

12 days ago

Codexis Announces New Employment Inducement Grants

Is There An Opportunity With Codexis, Inc.'s (NASDAQ:CDXS) 22% Undervaluation?
CDXS

Simply Wall St.

12 days ago

Is There An Opportunity With Codexis, Inc.'s (NASDAQ:CDXS) 22% Undervaluation?

CDXS

MT Newswires

20 days ago

Caribou Biosciences Names Sri Ryali CFO

Codexis, Inc.'s (NASDAQ:CDXS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last week
CDXS

Simply Wall St.

a month ago

Codexis, Inc.'s (NASDAQ:CDXS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last week

Codexis Announces New Employment Inducement Grants
CDXS

GlobeNewswire

2 months ago

Codexis Announces New Employment Inducement Grants

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
CDXS

GlobeNewswire

2 months ago

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference

Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
CDXS

GlobeNewswire

2 months ago

Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics

Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
CDXS

GlobeNewswire

2 months ago

Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
CDXS

GlobeNewswire

2 months ago

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics

Codexis Announces New Employment Inducement Grants
CDXS

GlobeNewswire

2 months ago

Codexis Announces New Employment Inducement Grants

Codexis to Participate in Upcoming Healthcare Conferences
CDXS

GlobeNewswire

3 months ago

Codexis to Participate in Upcoming Healthcare Conferences

Codexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.17
CDXS

Simply Wall St.

3 months ago

Codexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.17

Codexis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
CDXS

Simply Wall St.

3 months ago

Codexis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Codexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Focus ...
CDXS

GuruFocus.com

3 months ago

Codexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Focus ...

Promising Penny Stocks On US Exchanges In November 2024
CDXS

Simply Wall St.

3 months ago

Promising Penny Stocks On US Exchanges In November 2024

Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates
CDXS

Zacks

3 months ago

Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates

CDXS

Associated Press Finance

3 months ago

Codexis: Q3 Earnings Snapshot

Codexis Reports Third Quarter 2024 Financial Results
CDXS

GlobeNewswire

3 months ago

Codexis Reports Third Quarter 2024 Financial Results

Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
CDXS

GlobeNewswire

3 months ago

Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
CDXS

GlobeNewswire

3 months ago

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

Codexis announces employment inducement grants
CDXS

TipRanks

3 months ago

Codexis announces employment inducement grants

Codexis Announces New Employment Inducement Grants
CDXS

GlobeNewswire

3 months ago

Codexis Announces New Employment Inducement Grants

Codexis to Report Third Quarter 2024 Financial Results on October 31
CDXS

GlobeNewswire

3 months ago

Codexis to Report Third Quarter 2024 Financial Results on October 31

Codexis Inc (CDXS) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...
CDXS

GuruFocus.com

3 months ago

Codexis Inc (CDXS) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...

CDXS

MT Newswires

4 months ago

Codexis Expands Cash Reserves by $31 Million, Creates Chief Technology Officer Role

Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company
CDXS

GlobeNewswire

4 months ago

Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company

CDXS

MT Newswires

4 months ago

Codexis Enters License Agreement with Alphazyme for Life Science Enzymes

Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
CDXS

GlobeNewswire

4 months ago

Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences

Casdin Capital, LLC Increases Stake in Codexis Inc
CDXS

GuruFocus.com

4 months ago

Casdin Capital, LLC Increases Stake in Codexis Inc

CDXS

GuruFocus.com

4 months ago

Opaleye Management Inc. Expands Stake in Codexis Inc.

Opaleye Management Inc. Increases Stake in Codexis Inc.
CDXS

GuruFocus.com

4 months ago

Opaleye Management Inc. Increases Stake in Codexis Inc.

Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 7.4% Jump Turn into More Strength?
CDXS

Zacks

4 months ago

Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 7.4% Jump Turn into More Strength?

Pleasing Signs As A Number Of Insiders Buy Codexis Stock
CDXS

Simply Wall St.

4 months ago

Pleasing Signs As A Number Of Insiders Buy Codexis Stock

Codexis Announces New Employment Inducement Grants
CDXS

GlobeNewswire

5 months ago

Codexis Announces New Employment Inducement Grants

Codexis to Participate in Upcoming Healthcare Conferences
CDXS

GlobeNewswire

5 months ago

Codexis to Participate in Upcoming Healthcare Conferences

Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting
CDXS

GlobeNewswire

5 months ago

Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting

CDXS

MT Newswires

5 months ago

Benchmark Capital Downgrades Codexis to Hold From Buy

Codexis Announces New Employment Inducement Grants
CDXS

GlobeNewswire

5 months ago

Codexis Announces New Employment Inducement Grants

Codexis Publishes FY2023 Sustainability Disclosures
CDXS

GlobeNewswire

5 months ago

Codexis Publishes FY2023 Sustainability Disclosures

Codexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.83
CDXS

Simply Wall St.

5 months ago

Codexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.83

Codexis Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
CDXS

Simply Wall St.

5 months ago

Codexis Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates
CDXS

Zacks

5 months ago

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

CDXS

Associated Press Finance

5 months ago

Codexis: Q2 Earnings Snapshot

Codexis Reports Second Quarter 2024 Financial Results
CDXS

GlobeNewswire

5 months ago

Codexis Reports Second Quarter 2024 Financial Results

Codexis to Report Second Quarter 2024 Financial Results on August 8
CDXS

GlobeNewswire

6 months ago

Codexis to Report Second Quarter 2024 Financial Results on August 8

Beacon raises $170M for eye gene therapy; J&J confirms Carvykti survival benefit
CDXS

BioPharma Dive

7 months ago

Beacon raises $170M for eye gene therapy; J&J confirms Carvykti survival benefit

CDXS

MT Newswires

7 months ago

Codexis Sells Fabry, Pompe Disease Compounds to Crosswalk Therapeutics

Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets
CDXS

GlobeNewswire

7 months ago

Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets

Investors in Codexis (NASDAQ:CDXS) have unfortunately lost 88% over the last three years
CDXS

Simply Wall St.

7 months ago

Investors in Codexis (NASDAQ:CDXS) have unfortunately lost 88% over the last three years

Syntis Bio launches oral therapies for metabolic diseases
CDXS

Pharmaceutical Technology

7 months ago

Syntis Bio launches oral therapies for metabolic diseases

CDXS

MT Newswires

8 months ago

Cantor Fitzgerald Starts Codexis With Overweight Rating, $11 Price Target

Codexis to Participate in Jefferies Global Healthcare Conference
CDXS

GlobeNewswire

8 months ago

Codexis to Participate in Jefferies Global Healthcare Conference

Codexis to Participate in TD Cowen 2nd Annual Sustainability Week
CDXS

GlobeNewswire

8 months ago

Codexis to Participate in TD Cowen 2nd Annual Sustainability Week

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
CDXS

GlobeNewswire

8 months ago

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

Codexis First Quarter 2024 Earnings: Beats Expectations
CDXS

Simply Wall St.

9 months ago

Codexis First Quarter 2024 Earnings: Beats Expectations

Codexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call Transcript
CDXS

Insider Monkey

9 months ago

Codexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call Transcript

CDXS

Thomson Reuters StreetEvents

9 months ago

Q1 2024 Codexis Inc Earnings Call

CDXS

GuruFocus.com

9 months ago

Codexis Inc (CDXS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...

CDXS

GuruFocus.com

9 months ago

Codexis Inc (CDXS) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic Advances

CDXS

Associated Press Finance

9 months ago

Codexis: Q1 Earnings Snapshot

Codexis Reports First Quarter 2024 Financial Results
CDXS

GlobeNewswire

9 months ago

Codexis Reports First Quarter 2024 Financial Results

With 74% institutional ownership, Codexis, Inc. (NASDAQ:CDXS) is a favorite amongst the big guns
CDXS

Simply Wall St.

9 months ago

With 74% institutional ownership, Codexis, Inc. (NASDAQ:CDXS) is a favorite amongst the big guns

Codexis to Report First Quarter 2024 Financial Results on May 2
CDXS

GlobeNewswire

9 months ago

Codexis to Report First Quarter 2024 Financial Results on May 2

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
CDXS

GlobeNewswire

9 months ago

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

Favourable Signals For Codexis: Numerous Insiders Acquired Stock
CDXS

Simply Wall St.

10 months ago

Favourable Signals For Codexis: Numerous Insiders Acquired Stock

Codexis, Inc. (NASDAQ:CDXS) Q4 2023 Earnings Call Transcript
CDXS

Insider Monkey

a year ago

Codexis, Inc. (NASDAQ:CDXS) Q4 2023 Earnings Call Transcript

CDXS

Thomson Reuters StreetEvents

a year ago

Q4 2023 Codexis Inc Earnings Call

Codexis (CDXS) Tops Q4 Earnings and Revenue Estimates
CDXS

Zacks

a year ago

Codexis (CDXS) Tops Q4 Earnings and Revenue Estimates

CDXS

Associated Press Finance

a year ago

Codexis: Q4 Earnings Snapshot

CDXS

GuruFocus.com

a year ago

Codexis Inc (CDXS) Reports Fiscal Year 2023 Financial Results

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
CDXS

GlobeNewswire

a year ago

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche
CDXS

GlobeNewswire

a year ago

Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche

Codexis to Participate in TD Cowen 44th Annual Health Care Conference
CDXS

GlobeNewswire

a year ago

Codexis to Participate in TD Cowen 44th Annual Health Care Conference

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board
CDXS

GlobeNewswire

a year ago

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28
CDXS

GlobeNewswire

a year ago

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28

Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones
CDXS

GlobeNewswire

a year ago

Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones

seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting
CDXS

GlobeNewswire

a year ago

seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting

What Goldman Sachs and Morgan Stanley Told Investors
CDXS

Motley Fool

a year ago

What Goldman Sachs and Morgan Stanley Told Investors

Best Momentum Stocks to Buy for January 24th
CDXS

Zacks

a year ago

Best Momentum Stocks to Buy for January 24th

Westlake (NYSE:WLK) shareholders notch a 14% CAGR over 5 years, yet earnings have been shrinking
CDXS

Simply Wall St.

a year ago

Westlake (NYSE:WLK) shareholders notch a 14% CAGR over 5 years, yet earnings have been shrinking

World Acceptance Corporation (NASDAQ:WRLD) Q3 2024 Earnings Call Transcript
CDXS

Insider Monkey

a year ago

World Acceptance Corporation (NASDAQ:WRLD) Q3 2024 Earnings Call Transcript

Gannett (GCI) Shares Pulled Back in Q4
CDXS

Insider Monkey

a year ago

Gannett (GCI) Shares Pulled Back in Q4

Cibus 2023 Field Trial Results Move Developed Traits Closer to Product Sales
CDXS

GlobeNewswire

a year ago

Cibus 2023 Field Trial Results Move Developed Traits Closer to Product Sales

The past three years for Codexis (NASDAQ:CDXS) investors has not been profitable
CDXS

Simply Wall St.

a year ago

The past three years for Codexis (NASDAQ:CDXS) investors has not been profitable

Baillie Gifford Trims Position in Codexis Inc
CDXS

GuruFocus.com

a year ago

Baillie Gifford Trims Position in Codexis Inc

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
CDXS

GlobeNewswire

a year ago

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Financial Highlights

5 Top-Ranked Cathie Wood Stocks to Buy Right Now
CDXS

Zacks

a year ago

5 Top-Ranked Cathie Wood Stocks to Buy Right Now

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108
CDXS

GlobeNewswire

a year ago

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

Codexis, Inc. (NASDAQ:CDXS) Stock Rockets 41% But Many Are Still Ignoring The Company
CDXS

Simply Wall St.

a year ago

Codexis, Inc. (NASDAQ:CDXS) Stock Rockets 41% But Many Are Still Ignoring The Company

Park National (PRK) Soars 3.3%: Is Further Upside Left in the Stock?
CDXS

Zacks

a year ago

Park National (PRK) Soars 3.3%: Is Further Upside Left in the Stock?

American Vanguard Declares Quarterly Dividend
CDXS

Business Wire

a year ago

American Vanguard Declares Quarterly Dividend

Is It Time To Consider Buying Codexis, Inc. (NASDAQ:CDXS)?
CDXS

Simply Wall St.

a year ago

Is It Time To Consider Buying Codexis, Inc. (NASDAQ:CDXS)?

Insider Sell Alert: Director Elias Farhat Sells 35,177 Shares of Landsea Homes Corp (LSEA)
CDXS

GuruFocus.com

a year ago

Insider Sell Alert: Director Elias Farhat Sells 35,177 Shares of Landsea Homes Corp (LSEA)

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase
CDXS

GlobeNewswire

a year ago

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform
CDXS

GlobeNewswire

a year ago

Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform

OneSpan Inc. Announces Preliminary Results of Tender Offer
CDXS

Business Wire

a year ago

OneSpan Inc. Announces Preliminary Results of Tender Offer

Oil-Dri Corporation of America Insider Ups Holding During Year
CDXS

Simply Wall St.

a year ago

Oil-Dri Corporation of America Insider Ups Holding During Year

Cooper-Standard Holdings' (NYSE:CPS) investors will be pleased with their splendid 181% return over the last year
CDXS

Simply Wall St.

a year ago

Cooper-Standard Holdings' (NYSE:CPS) investors will be pleased with their splendid 181% return over the last year

Hibbett (NASDAQ:HIBB) Could Be A Buy For Its Upcoming Dividend
CDXS

Simply Wall St.

a year ago

Hibbett (NASDAQ:HIBB) Could Be A Buy For Its Upcoming Dividend

Share on Social Networks: